<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
 <url>
  <loc>https://www.dottnet.it/articolo/32544250/diabete-tipo-1-scoprirlo-prima-dei-sintomi-la-sfida-dello-screening-precoce</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Diabete tipo 1, scoprirlo prima dei sintomi: la sfida dello screening precoce</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544250-anteprimearticolidottnet-2026-11-02t112138152.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544251/diabete-cellule-staminali-e-terapia-genica-la-ricerca-prova-a-riattivare-la-produzione-di-insulina</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Diabete, cellule staminali e terapia genica: la ricerca prova a riattivare la produzione di insulina</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544251-anteprimearticolidottnet-2026-11-02t114213800.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544254/tumori-urologici-cure-su-misura-nel-tempo-la-biopsia-liquida-cambia-la-strategia</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tumori urologici, cure su misura nel tempo: la biopsia liquida cambia la strategia</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544254-anteprimearticolidottnet-2026-11-02t115246608.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544255/manovra-bertolaso-tagli-insostenibili-la-lombardia-non-cedera-</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Manovra, Bertolaso: &#34;Tagli insostenibili, la Lombardia non cederà&#34;</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544255-anteprimearticolidottnet39.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544257/cardiochirurgia-pediatrica-eurosets-presenta-trilly-baby-per-la-circolazione-extracorporea</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Cardiochirurgia pediatrica, Eurosets presenta Trilly Baby per la circolazione extracorporea</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544257-12.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544256/immunoglobuline-e-deanxit-il-prac-avvia-due-nuove-valutazioni-di-sicurezza</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Immunoglobuline e Deanxit, il PRAC avvia due nuove valutazioni di sicurezza</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544256-20944575.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544258/papillomatosi-respiratoria-ricorrente-negli-stati-uniti-arriva-voceryq-la-prima-immunoterapia-a-dna-plasmidico</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Papillomatosi respiratoria ricorrente, negli Stati Uniti arriva Voceryq: la prima immunoterapia a DNA plasmidico</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544258-20944893.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544259/vitamina-d-torna-la-campagna-dr-max-con-test-gratuiti-in-farmacia</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Vitamina D, torna la campagna Dr. Max con test gratuiti in farmacia</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544259-19199118.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544253/bollino-rosaverde-aperte-le-candidature-per-il-biennio-2027-2028</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Bollino RosaVerde, aperte le candidature per il biennio 2027-2028</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544253-senzatitolo.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544260/chiesi-paolo-paoletti-entra-nel-consiglio-di-amministrazione-focus-su-ricerca-e-innovazione</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Chiesi, Paolo Paoletti entra nel Consiglio di amministrazione: focus su ricerca e innovazione</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544260-20944364.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544261/aifa-approvata-la-rimborsabilita-di-9-nuove-opzioni-terapeutiche-novita-per-malattie-rare-oncologia-e-pediatria</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>AIFA, approvata la rimborsabilità di 9 nuove opzioni terapeutiche: novità per malattie rare, oncologia e pediatria</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544261-close-up-doctor-holding-pills21.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544262/farmacovigilanza-aifa-invita-i-medici-a-segnalare-gli-effetti-avversi</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmacovigilanza, Aifa invita i medici a segnalare gli effetti avversi</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544262-aifa.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544249/diabete-la-cura-guarda-oltre-la-glicemia-intelligenza-artificiale-e-nuovi-farmaci-cambiano-gli-obiettivi</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Diabete, la cura guarda oltre la glicemia: intelligenza artificiale e nuovi farmaci cambiano gli obiettivi</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544249-anteprimearticolidottnet-2026-11-02t110854452.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544247/payback-dispositivi-medici-imprese-contro-la-manovra-ricorsi-e-proteste</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Payback dispositivi medici, imprese contro la manovra: ricorsi e proteste</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544247-payback.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544246/farmaci-equivalenti-egualia-manovra-insufficiente-sulle-forniture</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmaci equivalenti, Egualia: manovra insufficiente sulle forniture</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544246-farmaciequivalenti.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544248/sanita-gimbe-25-8-miliardi-di-divario-tra-fondi-e-spesa-prevista</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Sanità, Gimbe: 25,8 miliardi di divario tra fondi e spesa prevista</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544248-cartabellotta.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544252/manovra-nursind-per-gli-infermieri-e-il-nulla-cosmico-</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Manovra, Nursind: &#34;Per gli infermieri è il nulla cosmico&#34;</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544252-infermieri4.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544245/carta-sanitaria-fnomceo-escluso-il-ministero-della-salute-</loc>
  <lastmod>2026-11-02T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Carta sanitaria, FNOMCEO: &#34;Escluso il ministero della Salute&#34;</news:title>
   <news:publication_date>2026-11-02</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544245-anzianoinfarmacia.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544266/clima-e-salute-l-intelligenza-artificiale-puo-prevedere-le-nuove-emergenze</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Clima e salute, l’intelligenza artificiale può prevedere le nuove emergenze</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544266-anteprimearticolidottnet-2026-11-03t111848203.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544265/fibrillazione-atriale-dopo-la-chiusura-dell-auricola-sinistra-meno-sanguinamenti-con-la-monoterapia</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Fibrillazione atriale, dopo la chiusura dell’auricola sinistra meno sanguinamenti con la monoterapia</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544265-cuore.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544268/diabete-bonadonna-alla-guida-della-sid-l-innovazione-deve-essere-accessibile-a-tutti-</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Diabete, Bonadonna alla guida della SID: «L’innovazione deve essere accessibile a tutti»</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544268-anteprimearticolidottnet-2026-11-03t112434587.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544264/manovra-ai-pazienti-un-documento-con-i-costi-delle-prestazioni-ssn</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Manovra, ai pazienti un documento con i costi delle prestazioni SSN</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544264-spesesanitarie.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544263/farmindustria-manovra-positiva-ma-restano-payback-e-criticita-mfn</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmindustria, manovra positiva ma restano payback e criticità Mfn</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544263-farmindustria.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544267/influenza-sorveglianza-ferma-da-otto-mesi-mancano-i-dati-nazionali</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Influenza, sorveglianza ferma da otto mesi: mancano i dati nazionali</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544267-anteprimearticolidottnet40.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544269/fascicolo-sanitario-il-garante-approva-l-accesso-agli-over-14</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Fascicolo sanitario, il Garante approva l’accesso agli over 14</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544269-fse3.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544270/medici-inps-pensione-enpam-compatibile-e-attivita-fino-a-72-anni</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Medici Inps, pensione Enpam compatibile e attività fino a 72 anni</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544270-pensione3.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544271/carcinoma-polmonare-a-piccole-cellule-astride-serplulimab-mostra-un-vantaggio-numerico-nella-sopravvivenza-rispetto-ad-atezolizumab</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Carcinoma polmonare a piccole cellule, ASTRIDE: serplulimab mostra un vantaggio numerico nella sopravvivenza rispetto ad atezolizumab</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544271-wavymed-04single-07.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544272/morbillo-negli-usa-4-852-casi-e-un-bimbo-morto-kennedy-sotto-accusa</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Morbillo, negli Usa 4.852 casi e un bimbo morto: Kennedy sotto accusa</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544272-morbillo.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544227/farmaci-da-banco-quasi-3-miliardi-di-euro-di-benefici-potenziali-il-valore-dell-automedicazione-responsabile</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmaci da banco, quasi 3 miliardi di euro di benefici potenziali: il valore dell’automedicazione responsabile</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544227-mhscl5.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32544273/sanita-10-miliardi-in-piu-ma-alle-regioni-non-bastano-scontro-sui-fondi</loc>
  <lastmod>2026-11-03T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Sanità, 10 miliardi in più ma alle Regioni non bastano: scontro sui fondi</news:title>
   <news:publication_date>2026-11-03</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32544273-fondosanitarionazionale.jpg</image:loc>
  </image:image>
 </url>
</urlset>